Orfiril Long (Sodium Valproate)

Sodium Valproate, the active ingredient in Orfiril Long, is an anticonvulsant presented as a oral tablet for systemic use. It is used to manage seizure disorders and is prescribed for both adult and pediatric patients. GNH USA supplies Orfiril Long as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Orfiril Long as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Orfiril Long is an anticonvulsant that acts on neuronal excitability in various seizure disorders.

- Epilepsy: Reduces the frequency and severity of generalized tonic‑clonic seizures. - Bipolar disorder: Stabilises mood and helps prevent manic episodes. - Migraine prophylaxis: Decreases the occurrence of migraine attacks. - Myoclonic seizures: Controls myoclonic jerks in patients with juvenile myoclonic epilepsy. - Status‑S ​       ​